The objective of this study was to analyze the relationship of polymorphisms of the angiotensin II AT1 receptor gene with microalbuminuria in a group of young adults with essential hypertension. Essential hypertensives, less than 50 years old, never previously treated with antihypertensive drugs, and in absence of diabetes mellitus were included. Office blood pressure (BP), 24-h ambulatory BP monitoring, urinary albumin excretion (UAE) measurements, and DNA analysis were performed. Polymorphisms of the angiotensin II AT1-receptor gene (A1166C and C573T) were studied by polymerase chain reaction and single-strand conformation polymorphism techniques. One hundred eighty-three patients, 49 (27%) microalbuminurics, were included. Office and ambulatory BP values were significantly higher in the microalbuminuria group. No differences in the presence of microalbuminuria were observed among the genotypes of either A1166C or C573T polymorphisms of the angiotensin II receptor AT1 gene, or in the allele frequency of the A1166C or the C573T polymorphism. LogUAE was significantly different among genotypes of the C573T polymorphism [CC 1.30(1.15-1.45), CT 1.14(1.00 -1.28), and TT 0.94(0.68 -1.20), P Ͻ .05]. Both office and ambulatory blood pressure and the TT/C573T genotype were independently related to logUAE, and, at the same BP values, UAE was lower in subjects with this genotype. We have found that the C573T polymorphism is on linkage disequilibrium with A1166C, as the 573T allele is closely linked to the presence of the 1166A allele, but not vice versa. Haplotype analysis among subjects with the AA genotype for the A1166C polymorphism confirms the influence of the TT genotype of the C573T polymorphism on the UAE in hypertensives. The C573T polymorphism of the angiotensin II receptor AT1 gene seems to be a genetic protective factor for UAE in a population of essential hypertensives. Am
D
uring the past few years microalbuminuria has become a marker of renal risk in diabetic subjects, 1 and a marker of cardiovascular risk in diabetic and nondiabetic elderly subjects. [2] [3] [4] Preliminary data supporting microalbuminuria as a prognostic marker for cardiovascular or renal risk in hypertension (HT) was recently reported, 5 and better knowledge of the determinants of microalbuminuria seems to be important to understanding the role of microalbuminuria in the management of HT. Previous studies from our group and others have demonstrated that in essential HT, microalbuminuria is related to the levels of blood pressure (BP), 4 -6 and to the presence of hyperinsulinemia 7, 8 as an expression of insulin resistance. 8 Notwithstanding, BP values and insulin resistance explain only in part the presence or absence of microalbuminuria in hypertensives. Genetic background, among others, could contribute to the development of microalbuminuria in HT. The renin-angiotensin system (RAS) plays a role in the pathobiology of vascular diseases, and genes controlling this system may be involved in the development of HT or in the establishment of end-organ damage. 9 -11 Angiotensin II AT-1 receptor mediates on most of the biological effects of angiotensin II on the vascular wall, and on the adrenal gland and kidney. The presence of the A1166C polymorphism of the angiotensin II type 1 receptor gene (AT1R) has been associated with HT, [12] [13] [14] pregnancyrelated HT, 15 left ventricular hypertrophy, 16 aortic stiff-ness, 17 and exaggerated vasoconstriction. 18 Moreover, a synergistic effect with the D allele of the angiotensinconverting enzyme gene polymorphism on risk of myocardial infarction was also described. 19 Association among other polymorphisms of the AT1R (T-810A in the 5Ј region, T55C in exon 4, C573T in exon 5) and BP levels has been reported as negative. 20 Studies focusing on the influence of polymorphisms of the RAS genes on microalbuminuria in essential HT are scarce. [21] [22] [23] To further study the influence of genetic background on microalbuminuria in HT, we analyzed the relationship of two polymorphisms of the AT1R, A1166C, and C573T, with urinary albumin excretion (UAE) in a group of young adults with essential HT. We found that the presence of a polymorphism in the AT1R, 573C3 T, seems to confer protection against the development of microalbuminuria in patients with essential HT.
Methods

Selection of Study Participants
Patients included in the study were selected from an outpatient clinic over a 5-year period (January 1990 to December 1994). All patients who fulfilled the inclusion criteria were invited to participate, and written consent was requested. The inclusion criteria were the following: 1) diastolic BP (DBP) ranging from high normal to moderate essential HT, defined as being between 85 and 114 mm Hg (Korotkoff phase V, sitting position) for three visits at 1-month intervals; 2) aged 25 to 50 years; 3) absence of cardiovascular events; 4) glomerular filtration rate greater than 60 mL/min/1.73 m 2 ; and 5) never previously treated for HT. Patients with nephropathy, diabetes mellitus, urinary tract infection, fasting glucose in serum Ͼ120 mg/dL or with a positive dipstick for albumin or glucose were excluded. One hundred eighty-three patients fulfilled the inclusion criteria.
Clinical and Analytical Procedures
Patients underwent a complete clinical work-up to rule out secondary HT. A 24-h ambulatory BP monitoring (ABPM), UAE measurements, and DNA analysis were performed. Blood pressure was measured in a quiet environment using a mercury sphygmomanometer with the patient in a sitting position after 5 min of rest, following the recommendations of the British Hypertension Society. Systolic BP (SBP) and DBP were measured according to Korotkoff phase I and phase V, respectively. Mean BP (MBP) was calculated using the equation: MBP ϭ DBP ϩ 1/3(SBP Ϫ DBP). In 140 of the subjects, the ABPM were performed using an oscillometric monitor, Spacelabs 90202 or 90207 (Redmont), on a regular work day, during one of the urine collection days.
Following the standard protocol, recording began between 08:30 and 09:00 with readings every 20 min from 06:00 until midnight and then every 30 min from midnight to 06:00. For the analysis of BP values obtained during monitoring, the average of SBP, DBP, and MBP were calculated for each recording during the 24-h period.
Blood samples were obtained in the morning, after fasting for a minimum of 8 h. Glomerular filtration rate was estimated by the clearance of endogenous creatinine as expressed in reference to body surface (mL/min/1.73 m 2 ). Urinary albumin excretion for two separate 24-h urine collections was measured using an immunonephelometric assay (Behring Institute, Mannheim, Germany). For each patient, the UAE was considered as the mean of values obtained in the two separate 24-h urine collections. On the basis of UAE, hypertensive patients were classified as normoalbuminuric (UAE, Ͻ30 mg/24 h) and microalbuminuric (UAE, 30 to 300 mg/24 h).
Analysis of Polymorphisms of Angiotensin II Receptor AT1 Gene
Genomic DNA was extracted from white blood cells. The region of the AT1R located between nucleotides 423 and 1278 of the cDNA 24 was amplified by using oligonucleotides 5Ј-GGCTTTGCTTTGTCTTGTTG and 5Ј-AATGCTTGTAGCCAAAGTCACCT as sense and antisense primers, respectively. The polymerase chain reaction product, 2.5 L, was digested with 0.5 U of FokI, which cuts at positions 799 and 1026, in a final volume of 5 L. The resulting fragments of 373, 227, and 252 bp were analyzed by the single-strand conformation polymorphism technique, using 10-by 10-cm gels of 10% acrylamide (29:1 acrylamide:bis-acrylamide), 10% glycerol and 1 ϫTEB. The total digestion volume was mixed with 5 L of loading buffer (95% formamide, 20 mmol/L EDTA, 1‰ of xylene cyanol and bromophenol blue). The DNA fragments were denatured by heating at 95°C during 2 min and chilled on ice; 1 L of the mix was loaded onto the gel and electrophoresed at 400 V for 3 h at 18°C. These conditions allowed us to simultaneously detect polymorphisms A1166C and C573T. The single-strand conformation polymorphism bands were correlated with the polymorphisms by direct polymerase chain reaction product sequencing.
Both polymorphisms were also analyzed by restriction analysis. The A1166C polymorphism was detected by digestion of the polymerase chain reaction product with DdeI, which cuts at positions 1167, when C is present at 1166 and 1023. The C573T polymorphism was detected by digestion with MnlI, which cuts at position 580, when C is present at 573, and at positions 905, 1032, 1062, and 1147. DNA fragments resulting from constant restriction sites for both enzymes were used as an internal digestion control.
Statistical Analysis
For each variable, the values were expressed as means and as 95% confidence intervals. Data on UAE were analyzed as a continuous variable with logarithmic transformation (logUAE). One-way analysis of variance, Kruskal-Wallis, and Fisher's tests were used to compare the parameters between patients with and without microalbuminuria, and among patients with different genotypes. Pearson's correlation coefficients were used to examine the linear relationship between UAE and other continuous variables. The association between polymorphisms and UAE was examined using a codominant inheritance model of the alleles (for A1166C polymorphism, AA v AC v CC; for C573T polymorphism, CC v CT v TT). The independent association between logUAE and other variables and the interaction of genotypes were examined by multiple regression analysis.
Nonrandom association between the polymorphisms analyzed was measured by standardized disequilibrium statistic (⌬) as described in Chakravarti et al. 25 The significance of ⌬ was tested by using n⌬ 2 (n ϭ number of chromosomes), which is distributed as a 2 with one degree of freedom.
Results
General Characteristics of the Study Population
The general characteristics, BP values, renal function, and UAE in the hypertensives enrolled in the study are shown in Table 1 . One hundred thirty-four (74%) of the patients were normoalbuminuric and 49 (26%) were microalbuminuric. The microalbuminuric group had significantly higher values than did the normoalbuminuric group for office MBP and DBP and for ambulatory SBP, MBP, and DBP.
Blood pressure values were positively related to logUAE, and Pearson's correlation coefficients between logUAE and BP were statistically significant (office: SBP r ϭ 0.17, P Ͻ .05; MBP r ϭ 0.24, P Ͻ .01; DBP r ϭ 0.24, P Ͻ .01; average of 24-h BP: SBP r ϭ 0.34, P Ͻ .01; MBP r ϭ 0.33, P Ͻ .01; DBP r ϭ 0.41, P Ͻ .01). In a multiple regression analysis including age and sex, the office MBP accounted for 5% of the UAE variance, and the average of the ambulatory MBP during 24 h for 12% of the UAE variance.
Genotypes of the A1166C and C573T Polymorphisms and UAE
Genotypes of the A1166C and C573T polymorphisms of the AT1R were in Hardy-Weinberg equilibrium. Genotype distribution and allele frequencies of both polymorphisms in the normalbuminurics and the microalbuminurics are in Table 2 . No differences in the presence of microalbuminuria were observed among the genotypes of either A1166C or C573T polymorphisms. The allele frequency of the A1166C or the C573T polymorphism was not significantly different between normoalbuminurics and microalbuminurics. such as age, sex, body mass index, office or ambulatory BP, and creatinine or creatinine clearance (data not shown).
Genotype influence of the A1166C and C573T Polymorphisms on the Relationship Between UAE and BP
The impact of the C573T genotype on the relationship between UAE and BP was analyzed by introducing the genotype into a stepwise multiple regression analysis in which logUAE was the independent variable, and age, sex, body mass index, and office MBP, the other dependent variables. Both office MBP and the genotype were independently related to logUAE, each factor accounting for about 7% and 5% of the variance, respectively (Table 3) . When a similar analysis was performed using the average of 24-h MBP instead of office MBP, the genotype factor remained significant. In this case, ambulatory MBP accounted for 12% and genotype for an additional 4% of the variances (Table 3 ). The graphic representation of this relationship is shown in Fig. 1 . The A1166C genotype did not influence the relationship between UAE and BP (data not shown).
Lingake Between A1166C and C573T Polymorphisms
Significant linkage disequilibrium was observed between the polymorphisms C573T and A1166C (Table 4 ). In our sample, all subjects with the TT/C573T genotype had the AA/A1166C genotype, but not vice versa. Moreover, we found only those genotypes that would indicate the presence of haplotypes 573C-1166A, 573C-1166C, and 573T-1166A, and we did not find those genotypes that would indicate the presence of haplotype 573T-1166C. These results support the idea that the C to T transition at base 573 is closely linked to the presence of the 1166A allele. If this is so, it can be assumed that genotype CT/C573T-AC/A1166C, for which it is not possible to estimate the haplotypes frequencies, comes from the same haplotypes found in those genotypes that are homozygous for at least one polymorphism, that is, it is composed by haplotypes Table 3 .
Relationships between LogUAE, office blood pressure, ambulatory blood pressure, and C573T polymorphism of the angiotensin II AT1-receptor gene 573T-1166A and 573C-1166C. In this way, a significant value of linkage disequilibrium between C573T and A1166C is found (⌬ ϭ 0.558; P Ͻ .0001). With the sample size used in this study, it would be unlikely (P Ͻ .05) to detect any allele with a frequency below 0.0079, according to (1 Ϫ x) n Ͻ 0.05, where x is the allele frequency and n is the number of chromosomes (n ϭ 376). Consequently, the frequency of the allele 573T-1166C, if it exists, must be lower than 0.0079.
As expected, among all subjects with the AA/A1166C genotype, both the amount of UAE as well as the percentage of microalbuminurics were significantly lower in the presence of the TT/C573T genotype, as compared to those with CC and CT/C573T genotypes [CC 1.30(1.15-1.45), CT 1.14(1.00 -1.28), and TT 0.94(0.68 -1.20), P Ͻ .05]. Likewise, the TT/C573T genotype independently influenced the relationship between BP and UAE (P Ͻ .004).
Discussion
In the present study we analyzed microalbuminuria as a surrogate end point of target end-organ damage in essential HT. Among a group of young adults with mild to moderate essential HT, never previously treated with antihypertensive drugs, 26% of them were microalbuminurics; a polymorphism in the 3Ј region of the AT1R, C573T, which is linkage disequilibrium to the A1166C polymorphism, seemed to confer protection against BPinduced UAE (Table 3 ). In contrast, no relationship was observed between UAE and the A1166C polymorphism of the AT1R in the same population. The low values of UAE observed among subjects homozygous for the T allele of the C573T polymorphism cannot be explained by differences in age, sex, body mass index, office BP, or ambulatory BP. The lowest values of UAE were present throughout the range of BP in TT genotype subjects ( fig.  1) . No other polymorphisms of the AT1R were analyzed because the study was performed before the detailed paper on the polymorphisms of the AT1R had been published. 20 Because our study focused on the impact of genetic polymorphisms in microalbuminuria for essential HT, we included hypertensives with selected characteristics, which allowed us to avoid several confounding factors. The age range (25 to 50 years) permitted us to avoid patients with vascular damage, which resulted in a mean age lower than previously reported in microalbuminuria studies. 2, 3, 5 Patients who were never previously treated with antihypertensive drugs were selected for a better estimation of the damage produced by HT, as the treatment of HT often decreases UAE. In addition, we took into account several important methodologic aspects of the target variable UAE, and of the assessment of BP. To reduce day-to-day variability, UAE was measured in two 24-h samples, one of them on the same day as the BP monitoring and another within 1 week. Ambulatory BP provides better assessment of BP values than office BP,
FIG. 1.
Relationship between log urinary albumin excretion (UAE) and ambulatory mean blood pressure (MBP) according to the genotypes of C573T polymorphism (CC, CT, and TT) in 140 hypertensive subjects. For each MBP tertile (lowest tertile Ͻ109 mm Hg, middle tertile 109 to 118 mm Hg, highest tertile Ͼ118 mm Hg), UAE decreases according to the presence of the T allele. The number of subjets in each group is in parentheses. and the monitoring of BP was carried out with wellvalidated Spacelabs monitors, 90202 and 90207. 26 According to the present data, UAE was related to MBP levels recorded in office measurements or during 24-h measurements, and to the genotype of the C573T polymorphism, but not to the A1166C polymorphism. The absence of an effect of the A1166C polymorphism on UAE was previously described for diabetes. 27 The main finding of the present study is the impact on UAE of a polymorphism in the AT1R, located at position 573. This is in linkage disequilibrium with the previously described A1166C polymorphism, in such a way that the C to T transition at nucleotide 573 is closely linked to the presence of 1166A allele. In contrast to the results obtained for the A1166C polymorphism, the presence of the T allele of the C573T polymorphism seems to protect against development of microalbuminuria.
The genotype distribution of the C573T polymorphism in the hypertensives included in the present study was not different from that observed in a Spanish normotensive population (CC 27.7%, CT 53.8%, TT 18.5%, FJ Chaves, unpublished data) and in a French hypertensive population. 12 Frequency distribution in non-whites is not available at present, but it might be particularly fruitful to investigate the black population, one prone to develop renal damage in the presence of HT. In the present study, the C573T polymorphism was not related to BP values in agreement with a previously published study. 12 Up to now, the mechanism or mechanisms accounting for the relationship of the C573T polymorphism with UAE remain unknown. Any modification of the expression or presence of angiotensin II AT1 receptors in the membrane can modify the effect of angiotensin II over the target tissues, and the lowest values of UAE could be ascribed to low activity of the receptor-mediated effects of angiotensin II. 21, 22 The C573T polymorphism does not change the sense of codon 191 (CTC3 CTT) that codifies for leucine. This polymorphism could be responsible for the alteration of the AT1 receptor function, or alternatively the presence of the 573T allele could be in linkage disequilibrium with other polymorphisms in the sequence of the AT1 gene, or with alterations in other genes located close to the 3q21-q25 region, where the AT1R lies in humans.
In conclusion, the C573T polymorphism of the AT1R modifies HT-induced UAE in a population of essential hypertensives. Further studies are needed to assess whether or not this effect results from genotype-mediated receptor activation. Furthermore, whether subjects carrying the T allele of AT1R C573T polymorphism have a lower risk of developing kidney damage, should be explored in hypertension and other kidney diseases.
